Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
221,364,370
-
Share change
-
+12,225,175
-
Total reported value
-
$9,335,930,183
-
Put/Call ratio
-
64%
-
Price per share
-
$42.16
-
Number of holders
-
779
-
Value change
-
+$526,241,074
-
Number of buys
-
373
-
Number of sells
-
313
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q1 2017
As of 31 Mar 2017,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
779 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
221,364,370 shares.
The largest 10 holders included
FMR LLC, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and Bank of New York Mellon Corp.
This page lists
779
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.